CBU
BIO icon

CIBC Bancorp USA’s Bio-Rad Laboratories Class A BIO Stock Holding History

CIBC Bancorp USA’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-120,120
Closed -$33.5M – 1945
2026
Q1 		$33.5M Buy
+120,120
New +$34.6M 0.05% 283

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

CIBC Bancorp USA's BIO Position: Q2 2026 in Review

CIBC Bancorp USA sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2026, closing a stake of 120,120 shares — an estimated $33.5M sold.

CIBC Bancorp USA first reported a position in BIO in Q1 2026 and held it in 1 quarter. The position peaked at $33.5M in Q1 2026. 370 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • CIBC Bancorp USA reported no remaining Bio-Rad Laboratories Class A position as of Q2 2026 after selling out during the quarter.
  • CIBC Bancorp USA sold 120,120 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $33.5M.
  • CIBC Bancorp USA first reported a position in Bio-Rad Laboratories Class A in Q1 2026 and held it in 1 quarter.
  • CIBC Bancorp USA's Bio-Rad Laboratories Class A position peaked at $33.5M in Q1 2026.
  • 370 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.